Review of Recent Data Evaluating the Impact of Atacicept on Long-Term Disease Modification in IgAN
Time: 11:00 am
day: Conference Day Two
Details:
- Investigating the role of cytokines BAFF and APRIL and B cells in the pathogenesis of IgAN
- Reviewing the goals of disease modification in IgAN with regards to Gd-IgA1, hematuria, proteinuria, and eGFR stabilization
- Examining the results of the ORIGIN2b 96-week open label extension study
